CompletedNCT03427892
Brexpiprazole for Depression in People With Bipolarity
About this title
Read the official source — NCT03427892Researchers studied Brexpiprazole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Medication studyAges 18–65United States
Understand this study
What did researchers investigate?
Researchers studied Brexpiprazole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: March 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03427892
- Official title
Show the full official title
Brexpiprazole for Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Brexpiprazole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Brexpiprazole.
Who was this study for?
Listed age limits: 18 years to 65 years.
